Annals of Coloproctology

Skip Navigation: Skip to contents

SEARCH: Search

Advanced Search

mobile menu button

Page Path: HOME > Browse Articles

Han Eol Park

1 Article

Efficacy and Safety of Ramosetron Injection for Nausea and Vomiting in Colorectal-Cancer Patients Undergoing a Laparoscopic Colectomy: A Randomized, Double-Blind, Comparative Study: Han Eol Park, Min Ki Kim, Won-Kyung Kang; Ann Coloproctol. 2018;34(1):36-41. Published online February 28, 2018; DOI: https://doi.org/10.3393/ac.2018.34.1.36

4,967 View
71 Download
6 Web of Science
9 Citations

Abstract PDF

Purpose

A laparoscopic colectomy in colorectal-cancer patients is usually associated with a high risk of postoperative nausea and vomiting (PONV). The purpose of this study is to evaluate the efficacy of injection of long-acting 5-hydroxytryptamine type 3 (5-HT₃) receptor antagonist for the reduction of PONV in patients with colorectal cancer.

Methods

A total of 48 patients scheduled to undergo a laparoscopic colectomy for colorectal cancer were randomized in a double-blinded fashion. Patients were randomly allocated to 1 of 2 groups and assigned to receive either 0.3 mg of ramosetron intravenously (group A, n = 25) or 2 mL of normal saline (placebo) (group B, n = 22) immediately after the operation. The incidence of PONV, the nausea severity scale score, the visual analogue scale (VAS) score for pain, the total amount of patient-controlled analgesia used, the recovery of bowel function, and morbidities were assessed at 1 hour and at 24, 48, and 72 hours after surgery.

Results

The baseline and the operative characteristics were similar between the groups (P > 0.05). The number of cases without PONV (complete response) was higher for group A (ramosetron) than group B (normal saline): 24 hours after surgery, 92.0% (23 of 25) for group A versus 54.5% (12 of 22) for group B; 48 hours after surgery, 92% (23 of 25) for group A versus 81.8% (18 of 22) for group B (both P < 0.05). No serious adverse events occurred.

Conclusion

Postoperative ramosetron injection is effective for the prevention of PONV after a laparoscopic colectomy in colorectal-cancer patients.

Citations

Citations to this article as recorded by

Postoperative ileus after digestive surgery: Network meta‐analysis of pharmacological intervention
Etienne Buscail, Thibault Planchamp, Guillaume Le Cosquer, Manon Bouchet, Julie Thevenin, Nicolas Carrere, Fabrice Muscari, Olivier Abbo, Charlotte Maulat, Ariane Weyl, Jean Pierre Duffas, Antoine Philis, Laurent Ghouti, Cindy Canivet, Jean Paul Motta, Na
British Journal of Clinical Pharmacology.2024; 90(1): 107. CrossRef
Cost-effectiveness of prophylactic ramosetron in the prevention of postoperative nausea and vomiting
David Suh, Dong-Won Kim, Seung-Mi Lee, Yu-Seon Jung, Sun-Young Jung, Chul-Min Kim, Kuo-Cherh Huang
PLOS ONE.2024; 19(10): e0309592. CrossRef
A Clinical Risk Analysis of Postoperative Nausea and Vomiting After Colorectal Cancer Surgery
Masatsugu Hiraki, Toshiya Tanaka, Mika Koga, Daisuke Miura, Eiji Sadashima, Hirofumi Sato, Shinji Mitsumizo, Kenji Kitahara
Journal of Coloproctology.2022; 42(03): 203. CrossRef
Comparing the effects of continuous infusion of esmolol and ramosetron alone and in combination on nausea and vomiting after laparoscopic cholecystectomy: A prospective, randomized, double-blind study
Jae Young Ji, Nan Seol Kim, Yong Han Seo, Ho Soon Jung, Hea Rim Chun, Jin Soo Park, Jeong Soo Choi, Jae Min Ahn, Woo Jong Kim
Medicine.2022; 101(35): e30105. CrossRef
Levosulpiride and Ramosetron for the Prevention of Postoperative Nausea and Vomiting in Laparoscopic Surgery
R. T. Ranjithkumar, Imran Sholapur, Ravi Bhat, C. Chandan Kumar
Anesthesia Essays & Researches.2022; 16(3): 307. CrossRef
Reducing ileus after colorectal surgery: A network meta-analysis of therapeutic interventions
James Ashcroft, Aminder Anthony Singh, Bhavna Ramachandran, Amir Habeeb, Victoria Hudson, Jeremy Meyer, Constantinos Simillis, Richard Justin Davies
Clinical Nutrition.2021; 40(7): 4772. CrossRef
Management strategies for the treatment and prevention of postoperative/postdischarge nausea and vomiting: an updated review
Ofelia Loani Elvir-Lazo, Paul F. White, Roya Yumul, Hillenn Cruz Eng
F1000Research.2020; 9: 983. CrossRef
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis
Stephanie Weibel, Gerta Rücker, Leopold HJ Eberhart, Nathan L Pace, Hannah M Hartl, Olivia L Jordan, Debora Mayer, Manuel Riemer, Maximilian S Schaefer, Diana Raj, Insa Backhaus, Antonia Helf, Tobias Schlesinger, Peter Kienbaum, Peter Kranke
Cochrane Database of Systematic Reviews.2020;[Epub] CrossRef
Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens
Jennifer Holder-Murray, Stephen A Esper, Michael L Boisen, Julie Gealey, Katie Meister, David S Medich, Kathirvel Subramaniam
Korean Journal of Anesthesiology.2019; 72(4): 344. CrossRef

TOP